EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Muscle Cathepsin B Treatment Improves Behavioral and Neurogenic Deficits in a Mouse Model of Alzheimer's Disease

Alejandro Pinto, Hazal Haytural, Cássio Morais Loss, Claudia Alvarez, Asude Ertas, Olivia Curtis, Alyssa R Williams, Grayson Murphy, Kenneth J Salleng, Sylvia Gografe, Nishant P Visavadiya, Andy V Khamoui und 5 weitere

Aging Cell · 2025-11 · 24 (11)

DOI: 10.1111/acel.70242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, online erschienen am 05.10.2025. Verfasst von Alejandro Pinto und 16 weiteren Autor:innen. Beteiligte Einrichtung: Stiles-Nicholson Brain Institute, Charles E. Schmidt College of Medicine, Florida Atlantic University, Jupiter, Florida, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Cathepsin B, Neurogenesis, Muscle, Skeletal. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden, NHLBI NIH HHS, Florida Department of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increasing evidence indicates skeletal muscle function is associated with cognition. Muscle‐secreted protease Cathepsin B (Ctsb) is linked to memory in animals and humans, but has an unclear role in neurodegenerative diseases. To address this question, we utilized an AAV‐vector‐mediated approach to express Ctsb in skeletal muscle of APP/PS1 Alzheimer's disease (AD) model mice. Mice were treated with Ctsb at 4 months of age, followed by behavioral analyses 6 months thereafter. Here we show that muscle‐targeted Ctsb treatment results in long‐term improvements in motor coordination, memory function, and adult hippocampal neurogenesis, while plaque pathology and neuroinflammation remain unchanged. Additionally, in AD mice, Ctsb treatment normalizes hippocampal, muscle, and plasma proteomic profiles to resemble that of wildtype (WT) controls. In AD mice, Ctsb increases the abundance of hippocampal proteins involved in mRNA metabolism and protein synthesis, including those relevant to adult neurogenesis and memory function. Furthermore, Ctsb treatment enhances plasma metabolic and mitochondrial processes. In muscle, Ctsb treatment elevates protein translation in AD mice, whereas in WT mice mitochondrial proteins decrease. In WT mice, Ctsb treatment causes memory deficits and results in protein profiles across tissues that are comparable to AD control mice. Overall, the biological changes in the treatment groups are consistent with effects on memory function. Thus, skeletal muscle Ctsb application has potential as an AD therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCathepsin BNeurogenesisMuscle, SkeletalBehavior, AnimalAnimalsMiceDisease Models, AnimalHippocampusMaleMice, Transgenic

Stichwörter der Autor:innen

Alzheimer's diseasecathepsin Bmemorymuscleneurogenesisproteomics

Substanzen

Cathepsin B

Autor:innen und Institutionen

  • Stiles-Nicholson Brain Institute, Charles E. Schmidt College of Medicine, Florida Atlantic University, Jupiter, Florida, USA.
  • Department of Exercise Science and Health Promotion, Florida Atlantic University, Boca Raton, Florida, USA.
  • Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
  • Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Institut de Pharmacologie Moléculaire et Cellulaire, Université Côte d'Azur & Centre National pour la Recherche Scientifique (CNRS), Valbonne, France.

Förderung

  • Novo Nordisk Fonden
  • NHLBI NIH HHS
  • Florida Department of Health
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Pinto, A., Haytural, H., Loss, C. M., Alvarez, C., Ertas, A., Curtis, O., Williams, A. R., Murphy, G., Salleng, K. J., Gografe, S., Visavadiya, N. P., Khamoui, A. V., Altıntaş, A., Kafri, T., Barres, R., Deshmukh, A. S., & van Praag, H. (2025). Muscle Cathepsin B Treatment Improves Behavioral and Neurogenic Deficits in a Mouse Model of Alzheimer's Disease. Aging Cell, 24(11). https://doi.org/10.1111/acel.70242

Vancouver

Pinto A, Haytural H, Loss CM, Alvarez C, Ertas A, Curtis O, et al. Muscle Cathepsin B Treatment Improves Behavioral and Neurogenic Deficits in a Mouse Model of Alzheimer's Disease. Aging Cell. 2025;24(11). doi:10.1111/acel.70242

BibTeX
@article{Pinto2025,
  author = {Pinto, Alejandro and Haytural, Hazal and Loss, Cássio Morais and Alvarez, Claudia and Ertas, Asude and Curtis, Olivia and Williams, Alyssa R and Murphy, Grayson and Salleng, Kenneth J and Gografe, Sylvia and Visavadiya, Nishant P and Khamoui, Andy V and Altıntaş, Ali and Kafri, Tal and Barres, Romain and Deshmukh, Atul S and van Praag, Henriette},
  title = {Muscle Cathepsin B Treatment Improves Behavioral and Neurogenic Deficits in a Mouse Model of Alzheimer's Disease},
  journal = {Aging Cell},
  year = {2025},
  volume = {24},
  number = {11},
  doi = {10.1111/acel.70242}
}
Kostenlos starten →